feed,title,long_url,short_url
MarketWatch,Gilead's remdesivir may benefit moderately ill COVID-19 patients but findings 'uncertain',http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/jMd2pPGVNKI/story.aspx,https://j.mp/2FOWwio
MarketWatch,Starbucks stock rises after upgrade on growing sales potential,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/EjrFlBCLQpY/story.aspx,https://j.mp/2QoEzt2
